HRT

Showing 6 posts of 6 posts found.

Jager-van Dijk is new Arletta Pharma Solutions CEO 

October 13, 2026
FDA, Female Sexual Disorders, Genito-Urinary system, HRT, Obstetrics & Gynaecology, specialty pharmaceuticals, women's health

Netherlands-based clinical-stage biopharmaceutical company developing innovative therapies for women with Female Sexual Disorders (FSD), Arletta Pharma Solutions has appointed Jeannette …

Five Facts about COPD

October 11, 2026
Medical Communications Asthma & COPD, COPD, Five Facts, HRT, Smoking Cessation, chronic bronchitis, emphysema, smoking

1 Chronic obstructive pulmonary disease is a group of progressive lung conditions, principally emphysema and chronic bronchitis, that restrict airflow …

Five Facts about NHS and primary care

September 5, 2026
Medical Communications Five Facts, HRT, NHS, primary care

1 Primary care is the front door to the NHS, but it extends well beyond general practice. It includes primary …

Five Facts about cardiovascular disease

August 9, 2026
Medical Communications Five Facts, HRT, cardiovascular disease, cvd

1 Cardiovascular disease (CVD) is an umbrella term for conditions affecting the heart and blood vessels, including coronary heart disease, …

Five Facts about the menopause

March 6, 2026
Medical Communications Five Facts, HRT, menopause, perimenopause

1 Menopause is when periods stop due to decreasing hormone levels. It generally begins between the ages of 45 and …

hal-gatewood-_jbclosdsd4-unsplash

FDA approves new nonhormonal medication for menopause hot flashes

May 15, 2023
Medical Communications FDA, HRT, Veozah, hot flashes, menopause

The US Food and Drug Administration (FDA) has announced its approval of Veozah (fezolinetant), an oral medication to treat moderate …

The Gateway to Local Adoption Series

Latest content